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Perceptions and experiences of taking oral hypoglycaemic agents
among people of Pakistani and Indian origin: qualitative study
Julia Lawton, Naureen Ahmad, Nina Hallowell, Lisa Hanna, Margaret Douglas
Abstract
Objective To explore British Pakistani and British Indian
patients’ perceptions and experiences of taking oral
hypoglycaemic agents (OHAs).
Design Observational cross sectional study using in-depth
interviews in English or Punjabi.
Setting and participants 32 patients of Pakistani and Indian
origin with type 2 diabetes, recruited from primary care and
community sources in Edinburgh, Scotland.
Results Respondents reported complex and ambivalent views
about OHAs, which reflected their ambivalent attitudes towards
Western drugs in general. Respondents considered OHAs to be
an important part of the diabetic regimen because they
perceived British healthcare professionals to be competent and
trustworthy prescribers, and they considered the medicines
available in Britain to be superior to those on the Indian
subcontinent. Despite this, some respondents made deliberate
efforts to reduce their tablet intake without being advised to do
so. Reasons for this included perceptions that drugs worked by
providing relief of symptoms and concerns that OHAs could be
detrimental to health if taken for long periods, in conjunction
with other drugs, or without traditional foods.
Conclusions British Pakistani and Indian patients’ perceptions
of their OHAs may partly derive from popular ideas about
drugs on the Indian subcontinent. Cultural factors need to be
understood and taken into consideration to ensure that these
patients are given appropriate advice and to avoid unnecessary
changes to prescriptions.
Introduction
Type 2 diabetes is a serious condition that can lead to complica-
tions such as heart disease, stroke, renal failure, amputation, and
blindness. It is at least four times more common among people
of South Asian origin resident in Britain than in the general
population.1 South Asians also have a higher risk of
complications of diabetes and a 40% higher mortality,2 a
situation partly attributable to their blood glucose control being
poorer and more erratic than that of white patients.1 Patients’ self
management and adherence to drugs are key to good glycaemic
control.3 However, adherence to prescribed oral hypoglycaemic
agents (OHAs) is poor,4 5 and South Asian patients may be less
anxious than white patients about adhering to their treatments
and may attach less importance to controlling their diabetes.6 It
is increasingly recognised that if adherence is to be improved,
patients’ perspectives must be better understood.5
Patient centred approaches, which focus on the meanings of
drugs in patients’ everyday lives,7 have been successfully used to
understand (white) patients’ adherence or non-adherence to
drugs for conditions such as hypertension and epilepsy.7 8 In this
study, we extended a patient centred approach to a hitherto
unstudied area—the attitudes of Pakistani and Indian patients
with type 2 diabetes towards, and experiences of, taking OHAs.
Our objective was to inform their future care, as minority ethnic
patients respond well to health related advice and interventions
if these are delivered in ways that are sensitive to their views and
cultural backgrounds.9
Methods
We used single, in-depth interviews that encouraged respond-
ents to display their own understandings and meanings and per-
mitted themes and hypotheses to be identified and tested during
the study that might not have been initially anticipated.10 As
important information and cultural nuances can be lost when
translators are used as part of the interview process,11 we used a
bilingual research fellow (NA) fluent in English and Punjabi to
do all the interviews.
Recruitment and sample
Recruiting South Asian patients can be difficult (particularly
when health professionals are the only recruiters), and several
methods may be needed to access a sample with broad ranging
characteristics and experiences.12 13 We recruited patients from
five general practices in Edinburgh, identified as having a high
proportion of Pakistani and Indian patients. Healthcare
professionals contacted patients by letter (in English, Urdu, and
Punjabi), inviting them to “opt in.” We also used face to face
recruitment and snowballing to access respondents from
Edinburgh’s Pakistani and Indian communities, making an effort
to include hard to reach groups, such as housebound patients
and those who had limited contact with health services and pro-
fessionals. All respondents were either Indian (n = 9) or Pakistani
(n = 23) (the proportions reflect the demography of South
Asians in Scotland (2001 census)), aged 18 years and over, and
diagnosed as having type 2 diabetes. We excluded Bangladeshis
because of the logistical problems of including a third language
group and the small numbers resident in Scotland (2001 census).
To ensure a diversity of experiences and views, we purposively
sampled respondents on the basis of their age, sex, length of time
since diagnosis, and preferred language (table). Recruitment
continued until no new themes emerged from the interviews. All
respondents provided written consent to participation.
Data collection
NA did the interviews in English and Punjabi. Respondents were
informed that NA was not a healthcare professional and were
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reassured about confidentiality. All interviews were conducted in
a sensitive and non-judgmental way. Among other topics,
interviews explored respondents’ perceptions of and views about
OHAs in a culturally and contextually sensitive way that took
account of the broader features of their lives (box 1). Interviews
normally took place in respondents’ homes, averaged one hour,
and were tape recorded with their consent. NA translated inter-
views into English (when necessary), and they were transcribed in
full. NA was assisted by a Pakistani and an Indian translator. They
checked tapes against the transcripts and were available for trou-
bleshooting when words or concepts did not easily translate
from Punjabi to English. We contacted some respondents after
the interviews to clarify issues and validate findings.
Analysis
The study was informed by grounded theory, which involves
concurrent data collection and analysis, together with systematic
efforts to check and refine developing categories of data.14
Themes and hypotheses identified in early interviews informed
questions in later interviews. Team members independently
reviewed interview data, and regular meetings were held to
explore respondents’ underlying reasoning, discuss deviant
cases, and reach agreement on recurrent themes and findings.
We used NUD*IST, a qualitative data indexing package, to facili-
tate coding and retrieval of data. We coded interviews according
to the areas described below.
Results
Twenty nine of the 32 respondents had direct experience of tak-
ing OHAs (table). Respondents reported complex and
ambivalent views about OHAs, which related to their ambivalent
views about Western medicines in general. As reported below,
respondents’ perceptions of drugs led some to adjust their
OHAs in ways that conflicted with medical advice. Responses did
not differ according to type of treatment, method of recruitment,
or characteristics of respondents outlined in the table.
Initial reactions to taking OHAs
Respondents expressed some initial trepidation about taking
OHAs, as they perceived this change to their regimen as signify-
ing that their condition had deteriorated and that they had taken
on the identity of a sick person:
“I was devastated [about being prescribed glipizide]. I wasn’t
happy at all. But it was explained to me that diabetes always
progresses, no matter how careful you are.” (R1, Pakistani,
female)
“If you start taking them, you become a patient.” (R11, Indian,
male)
Perceptions of OHAs
Despite their initial concerns, most of the respondents
prescribed OHAs perceived them as an essential part of their
diabetic regimen:
“If I didn’t take them then I would be in danger.” (R10, Paki-
stani, male)
“Once you start on these then you have to be on them for the
rest of your life. So either you do that, or you risk dying. So you
have no choice but to take the medicine.” (R12, Pakistani, female)
The perceived importance that respondents attached to
OHAs stemmed partly from their perception that these drugs
were more effective and of a better quality than those that could
be obtained on the Indian subcontinent:
“I don’t think you can get the same kinds of medicine that
you can get here, you know, like metformin. This is one of the
most important drugs to take for it.” (R2, Indian, male)
“See, in Pakistan, the medications are not right, they’re just a
waste of time, waste of money. I mean these [referring to OHAs]
are the real stuff. These are what really work.” (R7, Pakistani,
male)
Additionally, respondents considered British healthcare pro-
fessionals to be competent and trustworthy prescribers. Most
had had experiences of professionals and services on the Indian
subcontinent (because they were first generation migrants or
they had made extended visits to relatives) and used these as a
benchmark against which to assess the quality of care received in
Britain. Many respondents described health professionals on the
Characteristics of sample
Characteristic No of respondents
Age (years)
30-50 6
51-60 10
61-70 13
≥71 3
Sex
Male 15
Female 17
Years since diagnosis
0-5 9
6-10 10
11-15 5
≥16 8
Self reported fluency in English
High 13
Moderate 6
Low/nil 13
Religion
Muslim 22
Christian 1
Hindu 4
Sikh 5
Recruitment source
General practice 12
Community 20
Oral hypoglycaemic agents prescribed
Sulphonylurea 4
Metformin 12
Sulphonylurea plus metformin 13
None (diet controlled) 3
Head of household’s occupation*
Professional/higher managerial 7
Semiskilled (manual/non-manual) 16
Unskilled 7
Unknown 2
*Or former occupation for retired people.
Box 1: Topics covered in interviews
• Current and past diabetes treatment regimens
• Experiences of taking oral hypoglycaemic agents (OHAs) and
other drugs (including perceptions and understandings of
symptoms and side effects)
• Perceived efficacy of OHAs and other drugs (including
complementary therapies) in the short term and long term
• Commitment to adhering to OHAs and others regimens;
changes in commitment over time
• Experiences of health care and health professionals in Britain
and abroad
• Perceptions of past, present, and future health
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Indian subcontinent as untrustworthy, because they saw them as
lacking training and expertise, giving preferential treatment to
the wealthy and their own friends or relatives, and having a
financially vested interest in prescribing ineffective medications:
“You know how it is there, our doctors don’t really pay atten-
tion. They are more concerned with the amount of money they
are making. First they will give you a lighter medication, which
will make you go back to them again and again until they give
you something else. And by that time, you will be feeling better
anyway.” (R13, Pakistani, female)
In contrast, British health professionals were seen as “dealing
with everybody the same . . . they will treat according to their
condition” (R16, Pakistani, female), because they were paid
directly by the NHS and the NHS did not gain financially from
prescriptions being dispensed to patients. Because respondents
were confident that their OHAs had been appropriately
prescribed, most claimed that they had not sought out other
treatments for their diabetes, such as herbal remedies, either in
Britain or during visits to the Indian subcontinent.
Self regulation of OHAs
Despite attaching considerable importance to their OHAs, less
than half the respondents prescribed these drugs reported
taking them as prescribed. Fifteen people described how they
deliberately and routinely adjusted the amount of tablets they
took.With one possible exception, all these respondents said that
they would never exceed recommended dosages. Instead, they
attempted to reduce their tablet intake. Various factors seemed
to influence their self regulation practices.
Many respondents believed that drugs, including OHAs,
worked by providing instant relief of symptoms. Hence they
often saw it as unnecessary to take all of their OHAs when they
felt well: “You just can’t be bothered taking them for the sake of
it” (R27, Pakistani, female). Most claimed to be fully adherent
only on occasions when they felt lethargic or unwell:
“Sometimes you do say that to yourself, you know, you say to
yourself, ‘Oh I feel fine and I’ll take one today, I won’t take two.’ ”
(R27, Pakistani, female)
“They said that I need to take three, but for the last three
months I’m just taking them twice a day. It’s just when I feel I’m
tired I take another one. If I’m fine then I won’t.” (R26, Pakistani,
male)
Some respondents also described how they deliberately
skipped tablets to circumvent or mitigate unpleasant short term
side effects, without consulting or reporting these to health pro-
fessionals:
“So when I took them I would feel so much heat and I would
suddenly become dizzy. So then I didn’t take them.” (R23,
Pakistani, female)
“Sometimes I don’t take them, you know, they make you dry
if you take too many.” (R21, Pakistani, female)
Other respondents reported that they reduced their OHA
intake when they were fasting or they had to skip a meal, usually
without seeking medical advice. These respondents were
reluctant to take their OHAs without eating traditional
foodstuffs, such as curries and chapattis, as these foods were per-
ceived as having strengthening and fortifying properties that
balanced out, or counteracted, the side effects of their OHAs:
“If you keep on taking tablets and not eating strengthening
foods like roti, then they will affect you. If you eat strengthening
foods . . . they will not produce dryness.” (R16, Pakistani, female)
A few Pakistani respondents said that health professionals
had advised them to alter their OHA intake during Ramadan
and, because of this, they thought they could reduce their tablets
on other occasions, even though they had not been advised to do
so.
Respondents’ reluctance to take more OHAs than they saw
as necessary also stemmed from their perception that, by virtue
of being more potent and efficacious than medicines available
on the Indian subcontinent, OHAs could have hazardous effects.
These respondents articulated concerns that, if taken in excess or
over long periods, OHAs could be detrimental to their health:
“Yes, they told me to take it everyday, but I said ‘do I want to
die by taking it everyday. . . I don’t want to die by taking so many.’ ”
(R4, Pakistani, female)
“Already I am dull, my body is, by taking so many tablets.”
(R23, Pakistani, female)
Indeed, some respondents attributed the onset of their
diabetes to drugs that they had been prescribed for other condi-
tions, such as asthma, anaemia, and pneumonia. These respond-
ents also expressed anxieties about the long term health
implications of taking their OHAs in conjunction with other
drugs.
“Initially it was just two metformins a day, and then it was
increased to four by the doctor. And then there’s blood pressure
tablets to take and then aspirins and so on. So it all adds up and,
y’know, if you take seven, eight pills a day and you wonder [laugh]
is it the right thing? This can’t be good for me in the long run.”
(R2, Indian, male)
In a few cases, respondents also believed that taking several
medications together could counteract their individual effects:
“Instead of giving too many tablets why don’t they give one
instead? Like you drink tea and it’s good for your health, but if
you drink tea too hot or you add something to it then there is no
point in drinking the tea. It’s only worth it if you could have two
tablets instead of say 50.” (R25, Pakistani, male)
Self regulation strategies
Given their concerns about taking tablets in excess, some
respondents had devised strategies to reduce their intake of
OHAs.
Self monitoring
Most commonly, respondents self monitored their blood glucose
(sometimes in conjunction with physical activity) and took all
their tablets only when they considered their readings to be high:
“And now in the morning I take three pills, sometimes two,
meaning I check it [blood glucose] and according to that I do or
don’t take all the pills.” (R5, Pakistani, male)
In some cases, respondents were unaware of appropriate lev-
els for blood glucose control. One man, for example, claimed
that he only took all of his prescribed tablets when “it goes out of
control at 18 or 19.” (R26, Pakistani male)
Reducing food intake
A few respondents described how they deliberately reduced the
amount of food they consumed, or skipped meals, so that they
could take fewer tablets:
“I have missed tablets many times [laughs].”
Interviewer: “Do you take all of your tablets after your break-
fast?”
“Sometimes I will take two when I don’t spread too much jam
on my toast or even sometimes I don’t even spread any. If I feel
like a bit of a pleasure then I will put some on and then I will take
the extra tablets.” (R19, Pakistani, male)
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Discussion
By adopting a patient centred approach, we identified various
factors that may influence Pakistani and Indian patients’
adherence to oral hypoglycaemic agents. These included
confidence in British healthcare professionals as prescribers,
perceptions of Western medicines as efficacious, expectations
that drugs should provide instant relief of symptoms, and beliefs
that Western medicines can have detrimental effects if taken in
excess or without traditional foodstuffs. Respondents had to bal-
ance these competing concerns, which could lead them to self
regulate their OHAs in ways that they saw as rational but that
went against medical advice.
Reviews of the literature on adherence to drugs have shown
that non-adherence is a problem across all patients groups and is
especially common among people who have no symptoms or
have unpleasant side effects.15 16 Although it would be
problematic to argue that our findings are specific to British
Pakistanis and Indians, some underlying cultural factors may be
present. Popular ideas about medicines, derived from the Indian
subcontinent, may have informed the ways our respondents per-
ceived and took their OHAs.On the Indian subcontinent, people
commonly self medicate, make selective use of prescribed drugs,
and abandon drugs that do not provide prompt relief of
symptoms.17 18 This might explain why some respondents
adjusted their OHAs without seeking medical approval and
according to the presence or absence of symptoms. Likewise, our
respondents’ concerns about taking OHAs in excess may have
derived from popular ideas on the Indian subcontinent that
Western drugs are powerful but inherently dangerous.19
Health professionals need to be aware of the meanings and
understandings that Pakistani and Indian patients attach to
OHAs and other drugs and the implications these may have for
their diabetes and other self care practices. Health professionals
should try to establish how these patients actually take their
OHAs, as elevated glucose or glycated haemoglobin levels might
be due to missed doses rather than underprescribing. In these
cases, patients should be counselled about the importance of
adherence, including the rationale for and long term nature of
treatment. Given that patients may attempt to balance their
drugs with certain foodstuffs, dietary beliefs and practices should
be explored as part of the consultation. Although Muslim
patients would benefit from advice about adjusting doses when
they are fasting,20 care should be taken to ensure that mixed
messages are not sent out. If patients see it as acceptable to alter
their OHA intake when fasting, they may think that they can do
so on other occasions, without seeking advice.
If patients perceive side effects as an inevitable byproduct of
taking OHAs, they may not present promptly when they feel
unwell or volunteer side effects in consultations. Consequently,
both side effects of their drugs and intercurrent illnesses may not
be managed appropriately. This suggests that health profession-
als should question Pakistani and Indian patients directly and
opportunistically about any side effects and health problems
they may be having. They also need to stress the importance of
presenting if problems arise.
Key to improving adherence is good health provider-patient
communication (box 2).12 For Pakistani and Indian patients, this
may require not only an understanding of the cultural factors
that inform their beliefs and practices about treatment but also
that mechanisms are in place to ensure the effective transfer of
information. Bilingual link workers may have an important part
to play here, given their potential to provide a cultural bridge
between health professionals and patients.21 22
Strengths and limitations
This is the first qualitative study to look in depth at British Paki-
stani and Indian patients’ perceptions and experiences of taking
OHAs. Our method enabled us to access our respondents’ views
without using translators during the interviews, thereby enhanc-
ing the quality of the data. As we did not have access to respond-
ents’ clinical records, and did not use a longitudinal design, we
cannot determine the effect of adjustment of OHAs on
glycaemic control. A further limitation arises from the absence of
qualitative work involving members of the general population or
other minority ethnic groups that can be used for comparative
purposes. Given that these groups also encounter problems
adhering to their OHAs, this should be a priority for future
research.7 Finally, as this study focused on Indian and Pakistani
patients, most of whom emigrated from the Punjab region in the
north of the Indian subcontinent, this may limit the
generalisability of the findings to other South Asians. However,
the literature from southern part of the Indian subcontinent
indicates that perceptions of drugs and self prescription
practices are very similar to those observed in northern
regions.23 24
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What is already known on this topic
Poor adherence to prescribed oral hypoglycaemic agents
(OHAs) presents a serious problem for professionals who
deliver diabetes care
British South Asian patients have poor blood glucose
control compared with white patients and may be less
adherent to their treatment regimens
Adherence can be improved when patients are approached
in culturally sensitive ways
What this study adds
British Pakistani and Indian patients have ambivalent
attitudes towards OHAs, which may partly derive from
popular ideas about Western drugs on the Indian
subcontinent
Pakistani and Indian patients’ beliefs about Western
medicines may lead them to self regulate their OHAs in
ways that seem rational to them but go against medical
advice
Health professionals need to establish how and why
patients take their OHAs in order to improve adherence
and glycaemic control
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